Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001628280-25-029773

Options or other derivatives

  • Director acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marrazzo Jeffrey D Director 2025-06-04 Grant or award · Stock Option (right to buy) +55,000 55,000 D
Loading xslF345X05/wk-form4_1749161395.xml…